Myeloperoxidase (MPO) is a heme protein present in the granules of neu
trophils and monocytes. The activated neutrophil releases MPO into the
phagolysosome or into the extracellular space in response to a variet
y of agonists. During concomitant activation of the NADPH-dependent ox
idase, the stimulated neutrophil also generates hydrogen peroxide, and
in this way the MPO-hydrogen peroxide-halide system exerts its potent
microbicidal activity. Recent interest in MPO has extended well beyon
d the domain of innate host defense against infection and includes gen
eralized inflammatory diseases, atherosclerosis, and degenerative neur
ologic diseases. Search of the various data banks using the cDNA seque
nce for MPO has uncovered previously unsuspected relationships among p
eroxidatively active proteins in widely different species. In addition
, application of the analytical tools of cell and molecular biology ha
s allowed definition of specific genotypes underlying MPO deficiency a
nd the impact of particular mutations on the fate of MPO precursors al
ong the biosynthetic pathway. In parallel, such studies have allowed s
ignificant advances in understanding of the normal steps in MPO biosyn
thesis and intracellular targeting.